ATE523602T1 - Mit durch antipsychotika induzierten extrapyramidalen symptomen assoziierte rgs2- genotypen - Google Patents
Mit durch antipsychotika induzierten extrapyramidalen symptomen assoziierte rgs2- genotypenInfo
- Publication number
- ATE523602T1 ATE523602T1 AT07736444T AT07736444T ATE523602T1 AT E523602 T1 ATE523602 T1 AT E523602T1 AT 07736444 T AT07736444 T AT 07736444T AT 07736444 T AT07736444 T AT 07736444T AT E523602 T1 ATE523602 T1 AT E523602T1
- Authority
- AT
- Austria
- Prior art keywords
- extrapyramidal symptoms
- rgs2
- antipsychotics
- genotypes associated
- symptoms induced
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
- C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/106—Pharmacogenomics, i.e. genetic variability in individual responses to drugs and drug metabolism
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/156—Polymorphic or mutational markers
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/16—Primer sets for multiplex assays
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/172—Haplotypes
Landscapes
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Wood Science & Technology (AREA)
- Analytical Chemistry (AREA)
- Zoology (AREA)
- Genetics & Genomics (AREA)
- Engineering & Computer Science (AREA)
- Pathology (AREA)
- Immunology (AREA)
- Microbiology (AREA)
- Molecular Biology (AREA)
- Biotechnology (AREA)
- Biophysics (AREA)
- Physics & Mathematics (AREA)
- Biochemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US81259906P | 2006-06-12 | 2006-06-12 | |
PCT/IL2007/000704 WO2007144874A1 (en) | 2006-06-12 | 2007-06-12 | Rgs2 genotypes associated with extrapyramidal symptoms induced by antipsychotic medication |
Publications (1)
Publication Number | Publication Date |
---|---|
ATE523602T1 true ATE523602T1 (de) | 2011-09-15 |
Family
ID=38461906
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AT07736444T ATE523602T1 (de) | 2006-06-12 | 2007-06-12 | Mit durch antipsychotika induzierten extrapyramidalen symptomen assoziierte rgs2- genotypen |
Country Status (4)
Country | Link |
---|---|
US (2) | US20100021891A1 (de) |
EP (1) | EP2041304B1 (de) |
AT (1) | ATE523602T1 (de) |
WO (1) | WO2007144874A1 (de) |
Families Citing this family (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20100021891A1 (en) | 2006-06-12 | 2010-01-28 | Bernard Lerer | Rgs2 genotypes associated with extrapyramidal symptoms induced by antipsychotic medication |
US20130078637A1 (en) * | 2010-05-27 | 2013-03-28 | Hadasit Medical Research Services And Development Ltd. | Antipsychotic-induced parkinsonism genotypes and methods of using same |
US20130080182A1 (en) * | 2011-09-26 | 2013-03-28 | Athleticode Inc. | Methods For Using DNA Testing To Screen For Genotypes Relevant To Athleticism, Health And Risk Of Injury |
EP2948563B1 (de) * | 2013-01-25 | 2019-10-02 | Universitat de Barcelona | Verfahren zur vorhersage des ausbruchs von durch eine behandlung mit antipsychotika hervorgerufenen extrapyramidalen symptomen |
US10036247B2 (en) * | 2015-11-16 | 2018-07-31 | Baker Hughes, A Ge Company, Llc | Downhole fiber optic measurement of packers during fluid injection operations |
Family Cites Families (26)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3539573A (en) * | 1967-03-22 | 1970-11-10 | Jean Schmutz | 11-basic substituted dibenzodiazepines and dibenzothiazepines |
US4086350A (en) * | 1974-11-06 | 1978-04-25 | Smithkline Corporation | Pharmaceutical compositions and method of producing anti-psychotic activity without extrapyramidal symptoms |
US4458066A (en) * | 1980-02-29 | 1984-07-03 | University Patents, Inc. | Process for preparing polynucleotides |
US4804663A (en) * | 1985-03-27 | 1989-02-14 | Janssen Pharmaceutica N.V. | 3-piperidinyl-substituted 1,2-benzisoxazoles and 1,2-benzisothiazoles |
IE58370B1 (en) * | 1985-04-10 | 1993-09-08 | Lundbeck & Co As H | Indole derivatives |
US5348855A (en) * | 1986-03-05 | 1994-09-20 | Miles Inc. | Assay for nucleic acid sequences in an unpurified sample |
GB8607684D0 (en) * | 1986-03-27 | 1986-04-30 | Ici America Inc | Thiazepine compounds |
US4831031A (en) * | 1988-01-22 | 1989-05-16 | Pfizer Inc. | Aryl piperazinyl-(C2 or C4) alkylene heterocyclic compounds having neuroleptic activity |
ATE173508T1 (de) | 1988-05-20 | 1998-12-15 | Hoffmann La Roche | Befestigung von sequenzspezifischen proben |
US5006528A (en) * | 1988-10-31 | 1991-04-09 | Otsuka Pharmaceutical Co., Ltd. | Carbostyril derivatives |
US5238945A (en) * | 1989-04-11 | 1993-08-24 | H. Lundbeck A/S | Method of treating psychoses |
GB8908085D0 (en) * | 1989-04-11 | 1989-05-24 | Lundbeck & Co As H | New therapeutic use |
US5500343A (en) * | 1990-02-07 | 1996-03-19 | Board Of Regents, The University Of Texas System | Allelic association of the human dopamine(D2) receptor gene in compulsive disorders |
US5229382A (en) * | 1990-04-25 | 1993-07-20 | Lilly Industries Limited | 2-methyl-thieno-benzodiazepine |
US5137712A (en) * | 1990-08-31 | 1992-08-11 | The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services | Use of s-adenosyl-l-methionine (SAMe) to reverse and/or prevent supersensitivity, tolerance and extrapyramidal side effects induced by neuroleptic treatment |
US5312925A (en) * | 1992-09-01 | 1994-05-17 | Pfizer Inc. | Monohydrate of 5-(2-(4-(1,2-benzisothiazol-3-yl)-1-piperazinyl)-ethyl)-6-chloro-1,3-dihydro-2H-indol-2-one-hydrochloride |
US5593840A (en) * | 1993-01-27 | 1997-01-14 | Oncor, Inc. | Amplification of nucleic acid sequences |
US5324401A (en) * | 1993-02-05 | 1994-06-28 | Iowa State University Research Foundation, Inc. | Multiplexed fluorescence detector system for capillary electrophoresis |
US6951721B2 (en) * | 1996-02-12 | 2005-10-04 | Gene Logic Inc. | Method for determining the haplotype of a human BRCA1 gene |
US6844154B2 (en) * | 2000-04-04 | 2005-01-18 | Polygenyx, Inc. | High throughput methods for haplotyping |
WO2001079561A2 (en) | 2000-04-17 | 2001-10-25 | Liggett Stephen B | Alpha-2 adrenergic receptor polymorphisms |
MY129350A (en) * | 2001-04-25 | 2007-03-30 | Bristol Myers Squibb Co | Aripiprazole oral solution |
MXPA04001287A (es) * | 2001-08-10 | 2004-05-27 | Wyeth Corp | Ensayo de receptor unido a proteina g. |
ATE444489T1 (de) | 2003-10-17 | 2009-10-15 | Tata Inst Of Fundamental Res | Neuer test zum screening von antipsychotika |
US20100021891A1 (en) | 2006-06-12 | 2010-01-28 | Bernard Lerer | Rgs2 genotypes associated with extrapyramidal symptoms induced by antipsychotic medication |
CA2718887A1 (en) | 2008-03-19 | 2009-09-24 | Existence Genetics Llc | Genetic analysis |
-
2007
- 2007-06-12 US US12/304,430 patent/US20100021891A1/en not_active Abandoned
- 2007-06-12 EP EP07736444A patent/EP2041304B1/de not_active Not-in-force
- 2007-06-12 AT AT07736444T patent/ATE523602T1/de not_active IP Right Cessation
- 2007-06-12 WO PCT/IL2007/000704 patent/WO2007144874A1/en active Application Filing
-
2011
- 2011-06-07 US US13/155,199 patent/US8986929B2/en not_active Expired - Fee Related
Also Published As
Publication number | Publication date |
---|---|
US8986929B2 (en) | 2015-03-24 |
EP2041304A1 (de) | 2009-04-01 |
EP2041304B1 (de) | 2011-09-07 |
US20100021891A1 (en) | 2010-01-28 |
WO2007144874A1 (en) | 2007-12-21 |
US20110236896A1 (en) | 2011-09-29 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
NZ600235A (en) | Methods and compositions for the assessment of drug response | |
EP1934377A4 (de) | Verfahren und zusammensetzungen zur identifizierung von biomarkern mit eignung bei der diagnose und/oder behandlung biologischer zustände | |
AR065910A1 (es) | Marcadores biologicos pronosticos de la respuesta de la artritis reumatoide a los antagonistas de los linfocitos b | |
ATE509123T1 (de) | Hochauflösende hochdurchsatz-hla-genotypisierung mittels klonaler sequenzierung | |
ATE523602T1 (de) | Mit durch antipsychotika induzierten extrapyramidalen symptomen assoziierte rgs2- genotypen | |
DK1730315T3 (da) | Polymorphismer i NOD2/Card15 gen | |
MX340668B (es) | Polimorfismos de vegf y terapia de anti-angiogenesis. | |
WO2010060996A3 (en) | Prediction of lipid-metabotype-related physiological susceptibilities | |
EA201291228A1 (ru) | Биомаркер для детекции высокогорной адаптации и высокогорного отека легких | |
Minor | A common variant of the cardiomyopathy associated 5 gene (CMYA5) is associated with schizophrenia in Chinese population | |
Lee et al. | No association between AKT1 polymorphism and schizophrenia: A case–control study in a Korean population and a meta-analysis | |
Gizatullin et al. | The tryptophan hydroxylase (TPH) 2 gene unlike TPH-1 exhibits no association with stress-induced depression | |
EP2297325A4 (de) | Verfahren zur stratifizierung, prognose und diagnose von schizophrenie, mutierte nukleinsäuremoleküle und polypeptide | |
JP2011500046A5 (de) | ||
WO2009060210A3 (en) | Predictive test for adult dog body size | |
WO2009029587A3 (en) | Compositions and methods for diagnosing and treating macular degeneration | |
GB0514913D0 (en) | Polymorphism | |
GB0713364D0 (en) | Abnormal blood conditions | |
Xiong et al. | A pharmacogenetic study of risperidone on chemokine (C–C motif) ligand 2 (CCL2) in Chinese Han schizophrenia patients | |
EP2150627A4 (de) | Vorhersage der ansprechbarkeit auf behandlung mit acetylsalicylsäure über polymorphismus im apo-(a)-gen | |
Ahmad et al. | Association between the ionotropic glutamate receptor kainate3 (GRIK3) Ser310Ala polymorphism and schizophrenia in the Indian population | |
EP2016197A4 (de) | Mit koronarer herzkrankheit assoziierte genetische polymorphismen, nachweisverfahren dafür und verwendung davon | |
WO2011148379A3 (en) | Antipsychotic-induced parkinsonism genotypes and methods of using same | |
SE0402832D0 (sv) | Methods | |
BR112012026314A2 (pt) | biomarcador para função renal em pacientes com diabetes do tipo 2 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
RER | Ceased as to paragraph 5 lit. 3 law introducing patent treaties |